Skip to main content

Peer Review reports

From: AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

Original Submission
23 Dec 2020 Submitted Original manuscript
26 Jan 2021 Reviewed Reviewer Report
13 Apr 2021 Author responded Author comments - Dilawar Khan
Resubmission - Version 2
13 Apr 2021 Submitted Manuscript version 2
26 Apr 2021 Author responded Author comments - Dilawar Khan
Resubmission - Version 3
26 Apr 2021 Submitted Manuscript version 3
Publishing
27 May 2021 Editorially accepted
17 Jun 2021 Article published 10.1186/s12885-021-08450-y

You can find further information about peer review here.

Back to article page